Holocene Advisors’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
ACM
KGAMU
JCM
Holocene Advisors's CDLX Position: Q2 2022 in Review
Holocene Advisors sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 1,084 shares — an estimated $596K sold.
Holocene Advisors first reported a position in CDLX in Q3 2021 and held it in 3 quarters. The position peaked at $1.08M in Q3 2021. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.
- Holocene Advisors reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
- Holocene Advisors sold 1,084 Cardlytics shares in Q2 2022, an estimated $596K.
- Holocene Advisors first reported a position in Cardlytics in Q3 2021 and held it in 3 quarters.
- Holocene Advisors's Cardlytics position peaked at $1.08M in Q3 2021.
- 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.
Based on Holocene Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.